Increased urinary type IV collagen marks the development of glomerular pathology in diabetic d/db mice

Metabolism: Clinical and Experimental

Volumn 50, Issue 12, 2001, Pages 1435-1440

  Cohen, Margo P ^a   Lautenslager, Gregory T ^a   Shearman, Clyde W ^a  

^a Dept of Optics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; COLLAGEN TYPE 4; MESSENGER RNA;

AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOACCUMULATION; BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIABETIC NEPHROPATHY; DISEASE COURSE; DISEASE MARKER; GLOMERULUS FILTRATION; HISTOPATHOLOGY; IMMUNOASSAY; KIDNEY DISEASE; KIDNEY FUNCTION; MALE; MESANGIUM; MONITORING; MORPHOMETRICS; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; PROTEINURIA; SERUM; URINARY EXCRETION; URINE LEVEL;

EID: 0035655219     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1053/meta.2001.28074     Document Type: Article

References (48)

1. Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients
2. Cell and matrix components of the glomerular mesangium in type I diabetes
3. Phenotypic expression of collagen types in mesangial matrix of diabetic and nondiabetic rats
4. Glomerular structure and function diabetic nephropathy: Early to advanced stages
5. Structure function relationships in diabetic nephropathy
6. Expression of transforming growth factor β is elevated in human and experimental diabetic nephropathy
7. Overexpression of transforming growth factor-β1 mRNA is associated with up-regulation of glomerular tenascin and laminin gene expression in non-obese diabetic mice
8. Glycated albumin stimulates fibronectin gene expression in glomerular mesangial cells: Involvement of the transforming growth factor-β system
9. Activation of protein kinase C in glomerular cells in diabetes. Mechanisms and potential links to the pathogenesis of diabetic nephropathy
10. Altered expression and subcellular distribution of diacylglycerol-sensitive protein kinase C isoforms in diabetic rat glomerular cells
11. Glycated albumin stimulation of PKC-α activity is liked to increased collagen IV in mesangial cells
12. Studies in the diabetic mutant mouse
13. Evolution of renal function abnormalities in the db/db mouse that parallels the development human diabetic nephropathy
14. Measuring progression of diabetic nephropathy
15. Intact" nephrons as the primary origin of proteinuria in chronic renal disease. Study in the rat model of subtotal nephrectomy
16. Amelioration of diabetic nephropathy with monoclonal antibodies against glycated albumin
17. Prevention of diabetic nephropathy in db/db mice with glycated albumin antagonists
18. Inhibiting albumin glycation ameliorates diabetic nephropathy in the db/db mouse
19. Prevention of decline in renal function in the db/db mouse
20. Renal interstitial expansion in insulin-dependent diabetes mellitus in the kidney
21. The pathogenesis of chronic renal failure in diabetic nephropathy
22. Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal anti-transforming growth factor-β antibody in db/db diabetic mice
23. Prevention of diabetic nephropathy by diet control in the db/db mouse
24. The effect of chronic β-glycosidase inhibition on diabetic nephropathy in the db/db mouse
25. Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC-β inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes
26. Extracellular matrix proteins as early markers in diabetic nephropathy
27. Urinary type IV collagen as a marker of early diabetic nephropathy
28. Significance of urinary type IV collagen in patients with diabetic nephropathy using a highly sensitive one-step sandwich enzyme immunoassay
29. Type IV collagen as an early marker for diabetic nephropathy in non-insulin-dependent diabetes mellitus
30. Amadori glucose adducts modulate mesangial cell growth and collagen gene expression
31. Glomerular structure in nonproteinuric IDDM patients with various levels of albuminuria
32. Studies with the mutation, diabetes, in the mouse
33. Studies in the diabetic mutant mouse. I. Light microscopy and radioautography of pancreatic islets
34. Studies in the diabetic mutant mouse. I. Physiological factors associated with alterations in beta cell proliferation
35. Effect of duration of type I diabetes on the prevalence of stages of diabetic nephropathy defined by urinary albumin/creatinine ratio
36. Neutralization of TGF-β by anti-TGF-β antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice
37. In vivo biosynthesis and turnover of glomerular basement membrane in diabetic rats
38. Renal glomerular collagen synthesis in streptozotocin diabetes. Reversal of increased basement membrane synthesis with insulin therapy
39. Glomerulopathy in rats with streptozotocin diabetes. Accumulation glomerular basement membrane analogous to human diabetic nephropathy
40. Glomerular basement membrane thickening in rats with long-term alloxan diabetes
41. Blood glucose control and glomerular capillary basement membrane thickening in experimental diabetes
42. Kidney lesions in rats with severe long-term alloxan diabetes
43. Urinary measurement of transforming growth factor-β and type IV collagen as new markers of renal injury: Application in diabetic nephropathy
44. Serum and urinary concentrations of type IV collagen and laminin as a marker of microangiopathy in diabetes
45. Increased renal production of transforming growth factor-β1 in patients with type II diabetes
46. The renal TGF-β system in the db/db mouse model of diabetic nephropathy
47. Glomerular filtration surface in type I diabetes mellitus
48. Glomerular morphology by light microscopy in non-insulin dependent diabetes mellitus. Lack of glomerular hypertrophy